Alkis J Psaltis1, Peter-John Wormald2. 1. Department of Otolaryngology Head and Neck Surgery, The University of Adelaide, South Australia, 28 Woodville Road, Woodville, SA, 5011, Australia. alkis.psaltis@adelaide.edu.au. 2. Department of Otolaryngology Head and Neck Surgery, The University of Adelaide, South Australia, 28 Woodville Road, Woodville, SA, 5011, Australia.
Abstract
PURPOSE OF REVIEW: Perturbations in local microbiota have been demonstrated in many chronic inflammatory diseases including chronic rhinosinusitis (CRS). The purpose of this paper is to review the latest microbiome research as it pertains to CRS and establish whether there is any evidence supporting the microbiome hypothesis for CRS. Treatment factors that may influence the sinonasal microbiome as well as the role of probiotics are also discussed. RECENT FINDINGS: Despite significant heterogeneity in study design, tissue sampling, processing and bioinformatics analysis, consistent findings have emerged from the recent literature. Healthy individuals and CRS patients have similar overall bacterial burden of disease and share many common phylum. CRS patients, however, routinely show reductions in markers of biodiversity. Both medical and surgical treatments appear to influence the sinonasal microbiome, with certain bacterial strains associated with better treatment outcomes. The presence of microbial dysbiosis in CRS is now supported by numerous studies. Whether this dysbiosis is a cause or rather an association of the disease process still remains unclear. Although probiotic therapies show early promise, much larger studies are required to establish their real role as a treatment for CRS.
PURPOSE OF REVIEW: Perturbations in local microbiota have been demonstrated in many chronic inflammatory diseases including chronic rhinosinusitis (CRS). The purpose of this paper is to review the latest microbiome research as it pertains to CRS and establish whether there is any evidence supporting the microbiome hypothesis for CRS. Treatment factors that may influence the sinonasal microbiome as well as the role of probiotics are also discussed. RECENT FINDINGS: Despite significant heterogeneity in study design, tissue sampling, processing and bioinformatics analysis, consistent findings have emerged from the recent literature. Healthy individuals and CRSpatients have similar overall bacterial burden of disease and share many common phylum. CRSpatients, however, routinely show reductions in markers of biodiversity. Both medical and surgical treatments appear to influence the sinonasal microbiome, with certain bacterial strains associated with better treatment outcomes. The presence of microbial dysbiosis in CRS is now supported by numerous studies. Whether this dysbiosis is a cause or rather an association of the disease process still remains unclear. Although probiotic therapies show early promise, much larger studies are required to establish their real role as a treatment for CRS.
Authors: Leah J Hauser; Diana Ir; Todd T Kingdom; Charles E Robertson; Daniel N Frank; Vijay R Ramakrishnan Journal: Int Forum Allergy Rhinol Date: 2015-09-21 Impact factor: 3.858
Authors: Miling Yan; Sünje J Pamp; Julia Fukuyama; Peter H Hwang; Do-Yeon Cho; Susan Holmes; David A Relman Journal: Cell Host Microbe Date: 2013-12-11 Impact factor: 21.023
Authors: Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald Journal: Rhinology Date: 2012-03 Impact factor: 3.681
Authors: Shraddha S Mukerji; Melissa A Pynnonen; Hyungjin Myra Kim; Andrew Singer; Mark Tabor; Jeffrey E Terrell Journal: Otolaryngol Head Neck Surg Date: 2009-02 Impact factor: 3.497
Authors: Laura J Vandelaar; Blake Hanson; Michael Marino; William C Yao; Amber U Luong; Cesar A Arias; Vijay Ramakrishnan; Martin J Citardi Journal: OTO Open Date: 2019-09-17
Authors: Elizabeth Copeland; Katherine Leonard; Richard Carney; Justin Kong; Martin Forer; Yuresh Naidoo; Brian G G Oliver; Justin R Seymour; Stephen Woodcock; Catherine M Burke; Nicholas W Stow Journal: Front Cell Infect Microbiol Date: 2018-02-28 Impact factor: 5.293